We wrote a short note yesterday about RHC volumes. This is a follow on, using industry stats for general inferences.
Now the APRA data isn’t a perfect one for mapping to RHC sales, but still, there’s not a lot else out there to grab, and what hopefully leaps out from the below plot of PHI (private health insurance) payments to hospitals (hospitals only, the data drops out other stuff, including nursing homes etc) looks a lot better than the normal seasonal drop over the quarter (with your eyes, note that September is often lower than other months over time, most especially over the pandemic) and if maintained, means a lot fewer gaps in green relative to trend.
The below might be a touch easier, with the pre-pandemic trend line draw in (e.g only using data to just before 2020, in grey). Since COVID, it was a marked deceleration.
If RHC have put that behind them, hopefully all else will follow.
Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.
This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.
Please note that past performance is not a reliable indicator of future performance.
General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.
Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.